| Systemic inflammation in decompensated cirrhosis: characterization and role in acute‐on‐chronic liver failure J Clària, RE Stauber, MJ Coenraad, R Moreau, R Jalan, M Pavesi, ... Hepatology 64 (4), 1249-1264, 2016 | 792 | 2016 |
| Clinical course of acute‐on‐chronic liver failure syndrome and effects on prognosis T Gustot, J Fernandez, E Garcia, F Morando, P Caraceni, C Alessandria, ... Hepatology 62 (1), 243-252, 2015 | 726 | 2015 |
| Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ... The Lancet 391 (10138), 2417-2429, 2018 | 540 | 2018 |
| Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide S Piano, V Singh, P Caraceni, R Maiwall, C Alessandria, J Fernandez, ... Gastroenterology 156 (5), 1368-1380. e10, 2019 | 468 | 2019 |
| The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 423 | 2020 |
| Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF R Moreau, J Clària, F Aguilar, F Fenaille, JJ Lozano, C Junot, B Colsch, ... Journal of hepatology 72 (4), 688-701, 2020 | 291 | 2020 |
| PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 74 (5), 1097-1108, 2021 | 238 | 2021 |
| Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment G Zaccherini, E Weiss, R Moreau JHEP Reports 3 (1), 100176, 2021 | 179 | 2021 |
| Role of human albumin in the management of complications of liver cirrhosis M Bernardi, CS Ricci, G Zaccherini Journal of clinical and experimental hepatology 4 (4), 302-311, 2014 | 178 | 2014 |
| Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure F Wong, S Piano, V Singh, M Bartoletti, R Maiwall, C Alessandria, ... Journal of hepatology 74 (2), 330-339, 2021 | 143 | 2021 |
| Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial E Pose, L Napoleone, A Amin, D Campion, C Jimenez, S Piano, O Roux, ... The Lancet Gastroenterology & Hepatology 5 (1), 31-41, 2020 | 131 | 2020 |
| QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? M Bernardi, C Maggioli, V Dibra, G Zaccherini Expert review of gastroenterology & hepatology 6 (1), 57-66, 2012 | 131 | 2012 |
| Human albumin in the management of complications of liver cirrhosis M Bernardi, C Maggioli, G Zaccherini Critical care 16 (2), 211, 2012 | 125 | 2012 |
| The use of rifaximin in patients with cirrhosis P Caraceni, V Vargas, E Solà, C Alessandria, K de Wit, J Trebicka, ... Hepatology 74 (3), 1660-1673, 2021 | 113 | 2021 |
| Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects G Guaraldi, C Stentarelli, S Zona, G Orlando, F Carli, G Ligabue, ... Atherosclerosis 208 (1), 222-227, 2010 | 90 | 2010 |
| Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF G Zaccherini, F Aguilar, P Caraceni, J Clària, JJ Lozano, F Fenaille, ... Journal of hepatology 74 (5), 1117-1131, 2021 | 82 | 2021 |
| Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications M Baldassarre, M Naldi, G Zaccherini, M Bartoletti, A Antognoli, ... Hepatology 74 (4), 2058-2073, 2021 | 75 | 2021 |
| Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register PM Mannucci, A Nobili, L Pasina Internal and emergency medicine 13, 1191-1200, 2018 | 74 | 2018 |
| Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis FA Giannone, M Baldassarre, M Domenicali, G Zaccherini, F Trevisani, ... Laboratory investigation 92 (3), 384-395, 2012 | 69 | 2012 |
| On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites P Caraceni, M Tufoni, G Zaccherini, O Riggio, P Angeli, C Alessandria, ... Journal of Hepatology 74 (2), 340-349, 2021 | 64 | 2021 |
Paolo CaraceniUniversity of Bologna確認したメール アドレス: unibo.it
